Blair William & Co. IL Decreases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Blair William & Co. IL trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 62.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,767 shares of the financial services provider’s stock after selling 40,132 shares during the quarter. Blair William & Co. IL owned 0.05% of iShares Biotechnology ETF worth $3,142,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. National Bank of Canada FI boosted its stake in iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after acquiring an additional 229 shares during the last quarter. IFP Advisors Inc grew its stake in iShares Biotechnology ETF by 237.1% in the fourth quarter. IFP Advisors Inc now owns 16,018 shares of the financial services provider’s stock worth $2,118,000 after purchasing an additional 11,266 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $480,000. Main Management ETF Advisors LLC raised its stake in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after buying an additional 14,535 shares in the last quarter. Finally, Cullen Frost Bankers Inc. lifted its holdings in iShares Biotechnology ETF by 1.5% during the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock worth $748,000 after buying an additional 82 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.8 %

IBB stock opened at $127.90 on Tuesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The stock’s 50 day simple moving average is $136.07 and its 200 day simple moving average is $138.74. The firm has a market cap of $6.04 billion, a P/E ratio of 27.83 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.